Cargando…

Two Phenotype-Differentiated Acinetobacter baumannii Mutants That Survived in a Meropenem Selection Display Large Differences in Their Transcription Profiles

37662RM1 and 37662RM2 are two phenotypically different, carbapenem-resistant mutants of Acinetobacter baumannii 37662 isolate following selection with meropenem (MEM) at sub-inhibitory concentrations. 37662RM2 lacks capsule synthesis and shows dramatically increased biofilm formation, while 37662RM1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qianqian, Meng, Xiaobin, Gu, Hanfu, Chen, Xueqin, Yang, Huaqing, Qiao, Yangyang, Guo, Xuemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794425/ https://www.ncbi.nlm.nih.gov/pubmed/31649648 http://dx.doi.org/10.3389/fmicb.2019.02308

Ejemplares similares

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement
por: Balázs, Bence, et al.
Publicado: (2021)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Virulence of Acinetobacter baumannii Exhibiting Phenotypic Heterogeneous Growth against Meropenem in a Murine Thigh Infection Model
por: Neou, Evangelia, et al.
Publicado: (2013)

The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii
por: Zhang, Jiayuan, et al.
Publicado: (2022)

An Outer Membrane Protein YiaD Contributes to Adaptive Resistance of Meropenem in Acinetobacter baumannii
por: Han, Lei, et al.
Publicado: (2022)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
por: Rivani, Erizka, et al.
Publicado: (2022)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
por: Jiang, Zhihui, et al.
Publicado: (2018)

Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2022)

Blue Light Sensing BlsA-Mediated Modulation of Meropenem Resistance and Biofilm Formation in Acinetobacter baumannii
por: Yang, Jihye, et al.
Publicado: (2023)

Computational exploration of molecular flexibility and interaction of meropenem analogs with the active site of oxacillinase-23 in Acinetobacter baumannii
por: Ramachandran, Balajee, et al.
Publicado: (2023)

Impact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities
por: Beganovic, Maya, et al.
Publicado: (2017)

Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations
por: Wang, Jingjing, et al.
Publicado: (2019)

A LysR-Type Transcriptional Regulator Controls Multiple Phenotypes in Acinetobacter baumannii
por: Tierney, Aimee R. P., et al.
Publicado: (2021)

Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
por: Yang, Cheng-Hong, et al.
Publicado: (2019)

1542. The Evaluation of the In Vitro Synergy of Colistin in Combination with Meropenem and Tigecycline against 50 Multi-Drug-resistant Acinetobacter baumannii strains
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii - A case report
por: Liebchen, U., et al.
Publicado: (2019)

Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models
por: Kousovista, Rania, et al.
Publicado: (2021)

A rapid and simple method for constructing stable mutants of Acinetobacter baumannii
por: Aranda, Jesús, et al.
Publicado: (2010)

A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii
por: Chin, Chui Yoke, et al.
Publicado: (2018)

Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings
por: Iwasawa, Yurika, et al.
Publicado: (2018)

Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran
por: Valadan Tahbaz, Sahel, et al.
Publicado: (2019)

In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
por: Ju, Yong Guk, et al.
Publicado: (2022)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro
por: Güran, Mümtaz, et al.
Publicado: (2023)

2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism
por: Soares, Nelson C, et al.
Publicado: (2009)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

The Acinetobacter baumannii group: a systemic review
por: Zhang, Hua-zhong, et al.
Publicado: (2013)

Transcriptional Regulation of the Outer Membrane Protein A in Acinetobacter baumannii
por: Oh, Kyu-Wan, et al.
Publicado: (2020)

The VBNC state: a fundamental survival strategy of Acinetobacter baumannii
por: König, Patricia, et al.
Publicado: (2023)

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
por: Gill, Christian M, et al.
Publicado: (2023)

FALSE POSITIVE PHENOTYPIC DETECTION OF METALLO-BETA-LACTAMASES IN ACINETOBACTER BAUMANNII
por: Bedenić, Branka, et al.
Publicado: (2019)

Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii
por: Li, Zhaoyinqian, et al.
Publicado: (2021)

Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii
por: Valcek, Adam, et al.
Publicado: (2022)

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
por: Nordqvist, H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qg8adg319svm2rqcriq15f0mh2